Filing Flows › Profound Medical (PROF) › Q2 2026
Profound Medical (PROF) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Profound Medical (PROF) reported revenue of $2.5M for the second quarter 2026 (Q2 2026), +12% from a year earlier and -53% from the quarter before. Operating margin was -445.7%, net loss $9.5M (384.2% of revenue).
Profound Medical, Q2 2026: revenue $2.5M (+12% year over year), operating margin -445.7%, net loss $9.5M, operating cash flow −$11.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | -53% | +12% |
| Operating profit | −$11.1M | — | — |
| Net earnings | −$9.5M | — | — |
| Operating cash flow | −$11.3M | — | — |
What changed
Revenue was $2.5M in Q2 2026, up 12% year over year and down 53% from the previous quarter. Recurring - non-capital was the largest line at 65% of revenue. Capital equipment added $221K year over year (up 34%), 81% of the total change.
Gross margin was 78.4%, up 5.2 points from Q2 2025. Operating costs exceeded revenue by $11.1M, an operating margin of -445.7%. Operating expenses fell 16% while revenue rose 12%. The quarter ended with a net loss of $9.5M, wider than the previous quarter's $7.1M loss.
Operating cash flow was −$11.3M. Non-cash charges added back $135K of depreciation and amortization and $874K of share-based compensation. Working capital and other items used $2.8M.
Questions
What was Profound Medical's revenue in the second quarter 2026?
Profound Medical (PROF) reported revenue of $2.5M for the second quarter 2026 (Q2 2026), +12% from a year earlier and -53% from the quarter before.
Was Profound Medical profitable in the second quarter 2026?
Operating loss was $11.1M (-445.7% of revenue) and net loss $9.5M.
Source: Profound Medical 10-Q on SEC EDGAR.